Wintac gets nod to raise Rs 66.83 crore

27 Jul 2017 Evaluate

Wintac has received an approval for issue of 66.83 lakh equity shares on Rights basis to the existing shareholders of the company in the ratio of 3 : 2 i.e., 2 (two) shares for every 3 (three) shares held at a price of Rs 100 per share (Rs10 face value + Rs 90 premium per share) aggregating to Rs 66.83 crore.

The funds raised would be utilised to meet the capital expenditure on construction of New Manufacturing Facility and other corporate funds requirements and also to augment the long term working capital of the company. The board of directors at their meeting held on July 27, 2017, has approved for the same.

Wintac’s range of specialties includes Antifungal, Anticancer, Cardiovascular, Corticosterid , Antiemetic, Large and small volume injectable and Ophthalmic solutions. The company has also forayed into the field of critical care by manufacturing and marketing products targeted to the critically ill patients.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.